X0303 4 2008-10-09 0000885725 BOSTON SCIENTIFIC CORP BSX 0000901430 ABELE JOHN E ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 Common Stock 2008-10-09 4 S 0 8076 9.1283 D 50846548 D Common Stock 2008-10-09 4 S 0 244050 8.9995 D 50602498 D Common Stock 2008-10-09 4 S 0 462024 8.591 D 50140474 D Common Stock 2008-10-09 4 S 0 4160200 8.5209 D 45980274 D Common Stock 2008-10-10 4 S 0 375700 8.0187 D 45604574 D Common Stock 2008-10-10 4 S 0 951926 7.533 D 44652648 D Common Stock 2008-10-10 4 S 0 1093074 7.17 D 43559574 D Common Stock 2008-10-10 4 S 0 3816520 7.2967 D 39743054 D Common Stock 2008-10-10 4 S 0 10340 8 D 351098 I By Trust Common Stock 400000 I By Spouse The transactions reported on this Form 4 represent the automatic involuntary sale of Boston Scientific common stock. These shares were previously pledged to collateralize a loan. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $9.11 to $9.16. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $8.75 to $9.15. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $8.11 to $9.10. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $8.18 to $9.05. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.95 to $8.09. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.343 to $8.06. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $6.34 to $7.34. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $6.75 to $7.70. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.28 to $8.03. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. Common stock held by trust for the benefit of the reporting person's child of which the reporting person is a trustee. The reporting person disclaims beneficial ownership of these shares. Common stock held by the reporting person's wife. The reporting person disclaims beneficial ownership of these shares. /s/ Lawrence J. Knopf, Attorney-in-fact 2008-10-14